Transaction Details
- Date of Completion: October 6, 2026
- Shares Sold: 1,34,40,000 equity shares of ₹10 each
- Stake Represented: 17.92% of the equity share capital of Credo Advanced Chemicals Limited
- Aggregate Consideration: ₹37,63,20,000 (Rupees Thirty-Seven Crores Sixty-Three Lakhs and Twenty Thousand only)
- Post-Transaction Holding: The Company no longer holds any shareholding in CACL
Approval Process
The transaction was completed pursuant to:
- Approval granted by the Board of Directors at its meeting held on September 3, 2026
- Requisite approval of shareholders by way of special resolution under Section 180(1)(a) of the Companies Act, 2013
- Compliance with Regulation 37A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Advisory Services
Deloitte Touche Tohmatsu India LLP acted as exclusive advisor to the Company for this transaction.